APA (7th ed.) Citation

K, S., K, M., A, M., YI, K., K, I., E, T., . . . N, I. (2026). Tumefactive demyelinating lesion during B-cell depletion therapy by ofatumumab. Multiple sclerosis (Houndmills, Basingstoke, England), 32(2), 244. https://doi.org/10.1177/13524585251370086

Chicago Style (17th ed.) Citation

K, Shinoda, et al. "Tumefactive Demyelinating Lesion During B-cell Depletion Therapy by Ofatumumab." Multiple Sclerosis (Houndmills, Basingstoke, England) 32, no. 2 (2026): 244. https://doi.org/10.1177/13524585251370086.

MLA (9th ed.) Citation

K, Shinoda, et al. "Tumefactive Demyelinating Lesion During B-cell Depletion Therapy by Ofatumumab." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 32, no. 2, 2026, p. 244, https://doi.org/10.1177/13524585251370086.